Intrexon Reports Third Quarter 2019 Financial Results Nov 12, 2019 07:30AM
Fibrocell Science (FCSC) to be Acquired by Castle Creek Pharma for $3/Share Sep 12, 2019 05:42PM
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell Sep 12, 2019 05:40PM
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell Sep 12, 2019 05:40PM
Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational Highlights Aug 14, 2019 04:45PM
View Older Stories

Aug 14, 2019 04:45PM Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
May 30, 2019 08:00AM Fibrocell to Present at BIO International Convention 2019
May 30, 2019 08:00AM Fibrocell to Present at BIO International Convention 2019
May 29, 2019 08:08AM Fibrocell Science (FCSC) Granted FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for Treatment of RDEB
May 29, 2019 08:00AM Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEB
May 29, 2019 08:00AM Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEB
May 15, 2019 07:30AM Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational Highlights
May 15, 2019 07:30AM Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational Highlights
May 9, 2019 08:00AM Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights
May 9, 2019 08:00AM Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights
Apr 15, 2019 06:32AM Fibrocell Science (FCSC) Announces Pact with Castle Creek Pharma to Develop and Commercialize FCX-007 Gene Therapy
Apr 15, 2019 06:30AM Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
Apr 15, 2019 06:30AM Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
Apr 3, 2019 08:00AM Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors
Apr 3, 2019 08:00AM Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors
Mar 27, 2019 07:32AM Fibrocell Science (FCSC) Reports Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
Mar 27, 2019 07:30AM Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
Mar 27, 2019 07:30AM Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
Mar 20, 2019 08:00AM Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
Mar 20, 2019 08:00AM Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
Feb 6, 2019 08:00AM Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
Feb 6, 2019 08:00AM Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
Jan 16, 2019 08:00AM Fibrocell to Present at Phacilitate Leaders World 2019
Jan 16, 2019 08:00AM Fibrocell to Present at Phacilitate Leaders World 2019
Dec 11, 2018 08:00AM Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Dec 11, 2018 08:00AM Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Nov 13, 2018 08:00AM Fibrocell Reports Third Quarter 2018 Financial Results and Recent Highlights
Nov 13, 2018 08:00AM Fibrocell Reports Third Quarter 2018 Financial Results and Recent Highlights
Nov 8, 2018 04:10PM Intrexon Announces Third Quarter 2018 Financial Results
Nov 8, 2018 08:00AM Fibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent Highlights
Nov 8, 2018 08:00AM Fibrocell to Host Conference Call and Webcast on Tuesday, November 13, 2018 to Discuss Third Quarter 2018 Financial Results and Recent Highlights
Oct 25, 2018 08:15AM Fibrocell Science (FCSC) Receives FDA Guidance on Phase 3 Clinical Trial Design for FCX-007
Oct 25, 2018 08:00AM Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007
Oct 25, 2018 08:00AM Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007
Sep 26, 2018 08:00AM Fibrocell to Present at Upcoming Industry and Investor Conferences
Sep 26, 2018 08:00AM Fibrocell to Present at Upcoming Industry and Investor Conferences
Sep 25, 2018 08:06AM Fibrocell Science (FCSC) Secures $1.4M FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Sep 25, 2018 08:00AM Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Sep 25, 2018 08:00AM Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Sep 5, 2018 08:07AM Fibrocell Science (FCSC) Reports FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
Sep 5, 2018 08:00AM Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
Sep 5, 2018 08:00AM Fibrocell Announces FDA Fast Track Designation of FCX-013 for Treatment of Moderate to Severe Localized Scleroderma
Aug 29, 2018 08:00AM Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
Aug 29, 2018 08:00AM Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
Aug 9, 2018 04:57PM Intrexon Business Update and Conference Call
Aug 9, 2018 08:00AM Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
Aug 9, 2018 08:00AM Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
Aug 2, 2018 08:00AM Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights
Aug 2, 2018 08:00AM Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights
May 29, 2018 09:24AM Fibrocell Science (FCSC) Prices 2.04M Share Common Offering at $2.85/Sh
View Older Stories